🇺🇸 FDA
Patent

US 10512693

Pharmaceutical compositions comprising meloxicam

granted A61KA61K31/4439A61K31/5415

Quick answer

US patent 10512693 (Pharmaceutical compositions comprising meloxicam) held by AXSOME THERAPEUTICS, INC. expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AXSOME THERAPEUTICS, INC.
Grant date
Tue Dec 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/4439, A61K31/5415, A61K45/06, A61K47/02